Changchun High-tech: the company never values rumors from a single market as its guiding principle.

On March 6, Changchun High-Tech answered questions from investors on the interactive platform, stating that the company never relies on rumors in a single market as a guide for value, always focusing on research and development innovation and clinical value, continuously putting patients at the center and innovation as the driving force, and constantly strengthening core competitiveness. For its main products, the company will continue to leverage its advantages in brand, channels, quality, etc., and combine with the results of medical insurance negotiations to continuously promote the sales and promotion of relevant products. At the same time, the company has been actively promoting diversification and transformation in recent years, building on the foundation laid in the previous stages of growth hormone research, sales, and promotion, and will continue to empower new pipeline products, promoting a virtuous cycle of "sharing advantages and reusing resources". For specific information on new products and products under development, please refer to the company's relevant announcements.